TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS Co-Infection
Study findings from Yale University, Medical Department provide new insights into HIV/AIDS co-infection
June 9th, 2009
According to a study from the United States, "Isoniazid preventive treatment (IPT) has been recommended for human immunodeficiency virus (HIV) infected individuals. We used a mathematical model to simulate the benefits and risks of preventive treatment delivered through antiretroviral (ARV) clinics using clinical data from Botswana." "Preventive treatment was found to reduce the incidence of tuberculosis (TB) by at least 12 cases per 100 000 population per year versus the scenario without such treatment over a 50-year simulation. Isoniazid (INH) resistant TB was observed to increase by <1% per year, even when using pessimistic assumptions about resistance emergence....
Source: TB & Outbreaks Week (2009-06-09)
|
